US5053006A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Method for the permanent occlusion of arteries
Assignee: Individual
•
Filing: 1990-04-02
•
Granted: 1991-10-01
•
Expires: 2010-04-02
Abstract
Abstract A new, non-mechanical method of inducing the complete occlusion of arteries is disclosed. Arteries are occluded thrombotically by means of a rose bengal dye-sensitized photochemical reaction initiated in non-thrombogenic vascular endothelium by light at a wavelength sufficient to electronically excite the rose bengal molecules. To blood platelets, the rose bengal-photosensitized endothelial surface becomes thrombogenic; accordingly, platelet adherence is followed by intense platelet aggregation resulting in complete occlusion of the artery.
Inventors
- 👤 Brant D. Watson
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-28 10:12
CPC Classifications
A; A61; A61N; A61N5/00; A61N5/06; A61N5/0613; A61N5/062; A61B; A61B17/00; A61B17/12; A61N5/0601; A61B17/22; A61B2017/22082; A61B2017/22087
Claims Analysis
Total Claims: 25
Claim 1
Independent Claim
124 words
A method for the permanent occlusion of arteries having a diameter of at least 21 μm, which comprises the infusion of rose bengal dye into the bloodstream and irradiation of an individual artery with a laser light beam at a wavelength sufficient to electronically excite the rose bengal molecules, the laser light beam being focussed so as to maximize the overlap of its cross-sectional intensity profile with the distribution off photosensitizer dye bound to arterial endothelium, so that rose bengal dye absorbed to the luminal surface of the artery absorbs the light, thereby initiating a photochemical reaction resulting in photochemical injury to the vascular endothelium of the artery at the point of interaction of the rose bengal dye and the laser light light beam.
Claim 2
Independent Claim
124 words
A method for the permanent occlusion of arteries having a diameter of at least 21 μm, which comprises the infusion of rose bengal dye into the bloodstream and irradiation of an individual artery with a laser light beam at a wavelength sufficient to electronically excite the rose bengal molecules, the laser light beam being focussed so as to maximize the overlap of its cross-sectional intensity profile with the distribution off photosensitizer dye bound to arterial endothelium, so that rose bengal dye absorbed to the luminal surface of the artery absorbs the light, thereby initiating a photochemical reaction resulting in photochemical injury to the vascular endothelium of the artery at the point of interaction of the rose bengal dye and the laser light light beam.
Claim 3
Dependent Claim
42 words
The method of claim 1, wherein the concentration of the rose bengal dye in blood is in an amount sufficient to induce photochemical injury to the vascular endothelium at the point of interaction of the rose bengal dye with the light beam.
Claim 4
Dependent Claim
22 words
The method of claim 2, wherein the initial concentration of the rose bengal dye in blood does not exceed about 680 μM.
Claim 5
Dependent Claim
20 words
The method of claim 1, wherein the laser light beam is an argon laser beam of an argon ion laser.
Claim 6
Dependent Claim
29 words
The method of claim 4, wherein the argon ion laser is operated at a wavelength range sufficient to electronically excite the rose bengal molecules, thereby initiating the photochemical process.
Claim 7
Dependent Claim
18 words
The method of claim 5, wherein the argon ion laser is operated at a wavelength of 514.5 nm.
Claim 8
Dependent Claim
37 words
The method of claim 1, wherein the laser light beam is an argon laser beam and the concentration of the rose bengal dye in blood is in the range of about 130 μM to about 680 μM.
Claim 9
Dependent Claim
19 words
The method of claim 1, wherein the laser light beam is a helium-neon laser beam of a helium-neon laser.
Claim 10
Dependent Claim
28 words
The method of claim 8, wherein the helium-neon laser is operated at a wavelength range sufficient to electronically excite the rose bengal molecules, thereby initiating the photochemical process.
Claim 11
Dependent Claim
17 words
The method of claim 9, wherein the helium-neon laser is operated at a wavelength of 543.5 nm.
Claim 12
Dependent Claim
37 words
The method of claim 1, wherein the laser light beam is a helium-neon laser beam and the concentration of the rose bengal dye in blood is in the range of about 340 μM to about 680 μM.
Claim 13
Dependent Claim
20 words
The method of claim 1, wherein the laser light beam is a dye laser beam of an argon-pumped dye laser.
Claim 14
Dependent Claim
29 words
The method of claim 12, wherein the argon-pumped dye laser is operated at a wavelength range sufficient to electronically excite the rose bengal molecules, thereby initiating the photochemical process.
Claim 15
Dependent Claim
19 words
The method of claim 13, wherein the argon-pumped dye laser is operated at the optimal wavelength of 562 nm.
Claim 16
Dependent Claim
41 words
The method of claim 1, wherein the laser light beam is a dye laser beam of an argon-pumped dye laser and the concentration of the rose bengal in blood is in the range of about 45 μM to about 230 μM.
Claim 17
Dependent Claim
34 words
The method of claim 1, wherein the laser light beam is a gaussian laser beam and the beam waist of the gaussian laser light beam overlaps the arterial diameter by 6% on either side.
Claim 18
Independent Claim
124 words
A method for the permanent occlusion of arteries having a diameter of at least 21 μm, which comprises the infursion of erythrosin B dye into the blood stream and irradiation of an individual artery with a laser light beam at a wavelength sufficient to electronically excite the erythrosin B molecules, the laser light beam being focussed so as to maximize the overlap of its cross-sectional intensity profile with the distribution of photosensitizer dye bound to arterial endothelium, so that erythrosin B dye absorbed to the luminal surface of the artery absorbs the light, thereby initiating a photochemical reaction resulting in photochemical injury to the vascular endothelium of the artery at the point of interaction of the erythrosin B dye and the laser light beam.
Claim 19
Independent Claim
124 words
A method for the permanent occlusion of arteries having a diameter of at least 21 μm, which comprises the infursion of erythrosin B dye into the blood stream and irradiation of an individual artery with a laser light beam at a wavelength sufficient to electronically excite the erythrosin B molecules, the laser light beam being focussed so as to maximize the overlap of its cross-sectional intensity profile with the distribution of photosensitizer dye bound to arterial endothelium, so that erythrosin B dye absorbed to the luminal surface of the artery absorbs the light, thereby initiating a photochemical reaction resulting in photochemical injury to the vascular endothelium of the artery at the point of interaction of the erythrosin B dye and the laser light beam.
Claim 20
Dependent Claim
42 words
The method of claim 17, wherein the concentration of the erythrosin B dye in blood is in an amount sufficient to induce photochemical injury to the vascular endothelium at the point of interaction of the erythrosin B dye with the light beam.
Claim 21
Dependent Claim
20 words
The method of claim 14, wherein the laser light beam is an argon laser beam of an argon ion laser.
Claim 22
Dependent Claim
29 words
The method of claim 19, wherein the argon ion laser is operated at a wavelength range sufficient to electronically excite the erythrosin B molecules, thereby initiating the photochemical process.
Claim 23
Dependent Claim
18 words
The method of claim 20, wherein the argon ion laser is operated at a wavelength of 528.7 nm.
Claim 24
Dependent Claim
18 words
The method of claim 20, wherein the argon ion laser is operated at a wavelength of 514.5 nm.
Claim 25
Dependent Claim
33 words
The method of claim 17, wherein the laser light beam is a gaussian laser beam and the beam waist of the gaussian laser beam overlaps the arterial diameter by 6% on either side.
References Cited (Backward Citations)
US4268495A
Cited
US4597379A
Cited
US4672969A
Cited
US4799479A
Cited
US4637815A
Cited
US4735201A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1994-09-30 | 1995-04-01 | 1995-10-01 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1998-09-30 | 1999-04-01 | 1999-10-01 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2002-09-30 | 2003-04-01 | 2003-10-01 | $7700.00 | Window Closed / Lapsed |